Quantifying the tumor-immune ecosystem in non-small cell lung cancer (nsclc) to identify clinical biomarkers of therapy response
AssigneeH. Lee Moffitt Cancer Center and Research Institute, Inc.
InventorsAlexander R. A. ANDERSON, Mark ROBERTSON-TESSI, Chandler D. GATENBEE, Sandhya PRABHAKARAN
Life of this patent
Estimating the term…
Abstract
A method of processing medical image data to predict disease progression in non-small cell lung cancer (NSCLC) patients includes receiving a multiplexed tissue image comprising a plurality of cells stained for one or more markers, evaluating the multiplexed tissue image using a machine learning model, and predicting whether a patient's NSCLC will progress based on the evaluation of the multiplexed tissue image using the machine learning model.
Claims37
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of processing medical image data to predict disease progression in non-small cell lung cancer (NSCLC) patients, the method comprising:
- receiving a multiplexed tissue image comprising a plurality of cells stained for one or more markers;
- evaluating the multiplexed tissue image using a machine learning classifier model, wherein the machine learning classifier model classifies each of the plurality of cells as either stable or progressive;
- and
- predicting whether a patient's NSCLC will progress based on the evaluation of the multiplexed tissue image using the machine learning classifier model.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A system for processing medical image data related to non-small cell lung cancer (NSCLC), the system comprising:
- at least one processor;
- and
- memory having instructions stored thereon that, when executed by the at least one processor, cause the system to perform operations comprising:
- receiving a multiplexed tissue image comprising a plurality of cells stained for one or more markers;
- evaluating the multiplexed tissue image using one of a support vector machine (SVM) classifier or a boosted regression tree (BRT), wherein the SVM classifier classifies each of the plurality of cells as either stable or progressive, and wherein the BRT outputs a probability of NSCLC progression for each of a plurality of quadrants parsed from the multiplexed tissue image;
- and
- predicting whether a patient's NSCLC will progress based on the evaluation of the multiplexed tissue image using the SVM classifier or the BRT.
Dependencies are inferred from the claim text.